✦ LIBER ✦

Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study

✍ Scribed by Hirotaka Takama; Hideji Tanaka; Tomohiro Sudo; Tomohide Tamura; Yusuke Tanigawara

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic modelling of cefotaxime

✍ S. Urien; N. Laurent; J. Barre; M. Druguet; M. Bouvier D’yvoire; P. Maire 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 306 KB

Development and validation of a populati

✍ Bregt S. Kappelhoff; Alwin D. R. Huitema; Kristel M. L. Crommentuyn; Jan W. Muld 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Derivation and validation of a risk-fact

✍ Amarasinghe, H K; Johnson, N W; Lalloo, R; Kumaraarachchi, M; Warnakulasuriya, S 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 348 KB

Validation and Extension of the PREMM1,2

✍ Francesc Balaguer; Judith Balmaña; Sergi Castellví–Bel; Ewout W. Steyerberg; Mon 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Su2090 A Population Pharmacokinetic Mode

✍ Gao, Xiang; Krishnaswami, Sriram; Mukherjee, Arnab 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Predictors of transfer to rehabilitation

✍ Dinh, Michael; Bein, Kendall J.; Byrne, Chris; Nair, Indu; Petchell, Jeffrey; Ga 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 448 KB